AVITA Medical (RCEL) Operating Expenses (2018 - 2025)

AVITA Medical's Operating Expenses history runs 8 years deep, the most recent figure standing at $24.7 million for Q4 2025.

• Quarterly Operating Expenses fell 5.23% year-over-year to $24.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $101.4 million (down 9.3% YoY) and the FY2025 annual result came in at $101.4 million, down 9.31% from the prior year.
• Operating Expenses was $24.7 million for Q4 2025 at AVITA Medical, up from $23.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $38.8 million in Q3 2021 and bottomed at $13.2 million in Q1 2021.
• A 5-year average of $23.7 million and a median of $24.7 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2021 — Operating Expenses jumped 159.89% — and 2022, when it plunged 63.39%.
• AVITA Medical's Operating Expenses stood at $38.8 million in 2021, then sank by 54.7% to $17.6 million in 2022, then jumped by 40.6% to $24.7 million in 2023, then gained by 5.47% to $26.1 million in 2024, then fell by 5.23% to $24.7 million in 2025.
• Business Quant data shows RCEL's Operating Expenses at $24.7 million in Q4 2025, $23.0 million in Q3 2025, and $26.1 million in Q2 2025.